HomeWhat to Ask Before You Start Peptide Therapy

What to Ask Before You Start Peptide Therapy

Peptide therapy is sold widely and regulated lightly, which means the quality of what you get depends almost entirely on who you get it from. These are the questions worth asking before you start. A good provider will answer all seven without hesitation.

1. Where is it made, and by whom?

Ask for the name of the pharmacy. A 503A compounding pharmacy makes preparations for individual patients against a prescription; a 503B outsourcing facility manufactures in batches under stricter oversight. Neither is the same as a research-chemical supplier. If a product is labelled “for research use only” or “not for human consumption,” that labelling is not a formality.

2. What is this compound’s regulatory status today?

Ask directly whether the substance is FDA-approved (for most peptides the answer is no), and whether it appears on the FDA’s 503A Bulks List. Ask when they last checked. This area has moved repeatedly through 2025 and 2026, and a clinic working from a two-year-old understanding is not tracking it.

3. Who is prescribing it, and what are they licensed to do?

Compounded peptides are prescription products. Ask for the name and licence type of the prescriber — not the clinic’s name, the person’s. Ask whether that prescriber is the one evaluating you, and whether they will be reachable if something goes wrong at nine at night.

4. What is the evidence for my indication, specifically?

Not for peptides generally, and not in animals. For your condition, in humans. It is a fair question, and the honest answer is often “there isn’t much.” A provider who says so is more trustworthy than one who produces a mechanism instead. A mechanism explains how something might work; it is not evidence that it does.

5. What would make you stop?

Ask what result, or absence of result, would lead them to say this is not working and recommend stopping. A provider who has no stopping condition has an open-ended treatment plan, which is a business model rather than a clinical one.

6. What are the known risks, and what is simply unknown?

The honest answer for most of these compounds includes a large unknown category — long-term effects have not been characterised because the studies have not been done. You are entitled to hear that plainly before you decide.

7. What does it cost in total, and what happens if I stop?

Ask for the full course cost rather than the per-vial price, and ask what happens to any gains when you stop. These are almost always cash-pay, and the answer to the second question shapes whether the first is worth it.

A note on this clinic

Venturis Clinic does not provide peptide therapy. It is available through Alpha Men’s Clinic, a separate telehealth practice. Dr. Philipose retains a financial interest in Alpha Men’s Clinic.

If you want the underlying evidence picture, see the companion page on what the human research actually shows.

This page is educational and is not medical advice. Reviewed by Alvin Philipose, DC, ICCP · Last reviewed August 2026.